Human BC1, an iPSC line which was obtained from Dr. Linzhao Cheng’s lab at Johns Hopkins School of Medicine, was used in the study. This is an established cell line with published results [58 (link)]. Cells were cultured in StemFlex media (Gibco) on 6-well tissue culture plates coated with laminin (Biolamina). Cells were dissociated with StemPro Accutase (Gibco) into single-cell suspension and seeded in required density for the experiment. The ROCK inhibitor Y-27632 dihydrochloride (Tocris) was added on the first day of passage at a concentration of 10 µM. Cultured cells were tested to ensure they lack mycoplasma contamination.
Free full text: Click here